A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)

Clinical trial NCT01598311 · COMPLETED

Trial details

NCT number: NCT01598311
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2012-05-16
Primary completion: 2015-07-26
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.